Evaluation and Regulation of Oncology Drug Approval: Finding the Right Balance.
Publication
, Journal Article
Lyman, GH
Published in: JAMA Oncol
June 1, 2016
Duke Scholars
Published In
JAMA Oncol
DOI
EISSN
2374-2445
Publication Date
June 1, 2016
Volume
2
Issue
6
Start / End Page
728 / 729
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Treatment Outcome
- Neoplasms
- Humans
- Drug Evaluation
- Drug Approval
- Antineoplastic Agents
- 3211 Oncology and carcinogenesis
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H. (2016). Evaluation and Regulation of Oncology Drug Approval: Finding the Right Balance. JAMA Oncol, 2(6), 728–729. https://doi.org/10.1001/jamaoncol.2015.6477
Lyman, Gary H. “Evaluation and Regulation of Oncology Drug Approval: Finding the Right Balance.” JAMA Oncol 2, no. 6 (June 1, 2016): 728–29. https://doi.org/10.1001/jamaoncol.2015.6477.
Lyman GH. Evaluation and Regulation of Oncology Drug Approval: Finding the Right Balance. JAMA Oncol. 2016 Jun 1;2(6):728–9.
Lyman, Gary H. “Evaluation and Regulation of Oncology Drug Approval: Finding the Right Balance.” JAMA Oncol, vol. 2, no. 6, June 2016, pp. 728–29. Pubmed, doi:10.1001/jamaoncol.2015.6477.
Lyman GH. Evaluation and Regulation of Oncology Drug Approval: Finding the Right Balance. JAMA Oncol. 2016 Jun 1;2(6):728–729.
Published In
JAMA Oncol
DOI
EISSN
2374-2445
Publication Date
June 1, 2016
Volume
2
Issue
6
Start / End Page
728 / 729
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Treatment Outcome
- Neoplasms
- Humans
- Drug Evaluation
- Drug Approval
- Antineoplastic Agents
- 3211 Oncology and carcinogenesis
- 1117 Public Health and Health Services